Oral fluid nicotine markers to assess smoking status and recency of use

Therapeutic Drug Monitoring

Volumn 33, Issue 5, 2011, Pages 609-618

  Scheidweiler, Karl B ^a   Marrone, Gina F ^a   Shakleya, Diaa M ^a   Singleton, Edward G ^b   Heishman, Stephen J ^a   Huestis, Marilyn A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b STEVENSON UNIVERSITY   (United States)

Author keywords

liquid chromatography; mass spectrometry; metabolite; nicotine; oral fluid

Indexed keywords

3' HYDROXYCOTININE; BIOCHEMICAL MARKER; COTININE; DRUG METABOLITE; NICOTINE; NORCOTININE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CIGARETTE SMOKING; COMPARATIVE STUDY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENVIRONMENTAL EXPOSURE; FEMALE; FLUID INTAKE; HUMAN; LIQUID CHROMATOGRAPHY; MALE; METABOLITE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SELF REPORT; TANDEM MASS SPECTROMETRY;

ADMINISTRATION, ORAL; ADULT; BIOLOGICAL MARKERS; COTININE; FEMALE; HUMANS; MALE; MIDDLE AGED; NICOTINE; SALIVA; SMOKING; YOUNG ADULT;

EID: 84860390148     PISSN: 01634356     EISSN: 15363694     Source Type: Journal    
DOI: 10.1097/FTD.0b013e318228ba39     Document Type: Article

References (32)

1. Bosker WM, Huestis MA. Oral fluid testing for drugs of abuse. Clin Chem. 2009;55:1910-1931.
2. Crouch DJ. Oral fluid collection: the neglected variable in oral fluid testing. Forensic Sci Int. 2005;150:165-173. (Pubitemid 41583219)
3. Substance Abuse and Mental Health Services Administration.Results from the 2009 National Survey on Drug Use and Health: National Findings Office of Applied Studies, ed. NSDUH Series H-38A. DHHS Publication No. SMA 10-4586 Findings. Rockville, MD: Department of Health and Human Services (DHHS); 2010.
4. Centers for Disease Control and Prevention. Smoking & Tobacco Use [Fast Facts]. March 21, 2011. Available at: http://www.cdc.gov/tobacco/data- statistics/fact-sheets/fast-facts/index.htm. Accessed March 28, 2011.
5. Hukkanen J, Jacob P 3rd, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57:79-115. (Pubitemid 40283970)
6. Benowitz NL, Hukkanen J, Jacob P 3rd. Nicotine chemistry, metabolism, kinetics and biomarkers. Handb Exp Pharmacol. 2009:29-60.
7. Benowitz NL, Jacob P 3rd. Metabolism of nicotine to cotinine studied by a dual stable isotope method. Clin Pharmacol Ther. 1994;56:483-493. (Pubitemid 24370355)
8. Zevin S, Jacob P 3rd, Benowitz N. Cotinine effects on nicotine metabolism. Clin Pharmacol Ther. 1997;61:649-654. (Pubitemid 27279926)
9. Benowitz NL, Jacob P 3rd. Trans-3'-hydroxycotinine: disposition kinetics, effects and plasma levels during cigarette smoking. Br J Clin Pharmacol. 2001;51:53-59. (Pubitemid 32118820)
10. Binnie V, McHugh S, Macpherson L, et al. The validation of self-reported smoking status by analysing cotinine levels in stimulated and unstimulated saliva, serum and urine. Oral Dis. 2004;10:287-293. (Pubitemid 39295441)
11. Blackford AL, Yang G, Hernandez-Avila M, et al. Cotinine concentration in smokers from different countries: relationship with amount smoked and cigarette type. Cancer Epidemiol Biomarkers Prev. 2006;15:1799-1804. (Pubitemid 44664251)
12. Curvall M, Elwin CE, Kazemi-Vala E, et al. The pharmacokinetics of cotinine in plasma and saliva from non-smoking healthy volunteers. Eur J Clin Pharmacol. 1990;38:281-287. (Pubitemid 20137482)
13. Dempsey D, Tutka P, Jacob P 3rd, et al. Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity. Clin Pharmacol Ther. 2004;76:64-72. (Pubitemid 38844735)
14. Etter JF, Vu Duc T, Perneger TV. Saliva cotinine levels in smokers and nonsmokers. Am J Epidemiol. 2000;151:251-258. (Pubitemid 30463629)
15. Figueiredo VC, Szklo M, Szklo AS, et al. Determinants of salivary cotinine level: a population-based study in Brazil. Rev Saude Publica. 2007;41: 954-962.
16. Jaakkola MS, Ma J, Yang G, et al. Determinants of salivary cotinine concentrations in Chinese male smokers. Prev Med. 2003;36:282-290. (Pubitemid 36299080)
17. Miller EI, Norris HR, Rollins DE, et al. Identification and quantification of nicotine biomarkers in human oral fluid from individuals receiving low-dose transdermal nicotine: a preliminary study. J Anal Toxicol. 2010;34:357-366.
18. Norregaard J, Tonnesen P, Simonsen K, et al. Long-term nicotine substitution after application of a 16-hour nicotine patch in smoking cessation. Eur J Clin Pharmacol. 1992;43:57-60.
19. Rubinstein ML, Thompson PJ, Benowitz NL, et al. Cotinine levels in relation to smoking behavior and addiction in young adolescent smokers. Nicotine Tob Res. 2007;9:129-135. (Pubitemid 47009052)
20. Prokhorov AV, De Moor C, Pallonen UE, et al. Validation of the modified Fagerstrom tolerance questionnaire with salivary cotinine among adolescents. Addict Behav. 2000;25:429-433. (Pubitemid 30235136)
21. Huang CL, Cheng CP, Lin HH, et al. Psychometric testing of the Chinese version of the Hooked on Nicotine Checklist in adolescents. J Adolesc Health. 2009;45:281-285.
22. Levi M, Dempsey DA, Benowitz NL, et al. Prediction methods for nicotine clearance using cotinine and 3-hydroxy-cotinine spot saliva samples II. Model application. J Pharmacokinet Pharmacodyn. 2007;34:23-34. (Pubitemid 46122546)
23. Levi M, Dempsey DA, Benowitz NL, et al. Population pharmacokinetics of nicotine and its metabolites I. Model development. J Pharmacokinet Pharmacodyn. 2007;34:5-21. (Pubitemid 46122545)
24. Nymox Corporation. NicAlert: Product Insert. Available at: http://www.nymox.com/default.action?itemid=47. AccessedMarch 28, 2011
25. Shakleya DM, Huestis MA. Optimization and validation of a liquid chromatography-tandem mass spectrometry method for the simultaneous quantification of nicotine, cotinine, trans-3'-hydroxycotinine and norcotinine in human oral fluid. Anal Bioanal Chem. 2009;395:2349-2357.
26. Caraballo RS, Giovino GA, Pechacek TF, et al. Racial and ethnic differences in serum cotinine levels of cigarette smokers: Third National Health and Nutrition Examination Survey, 1988-1991. JAMA. 1998;280: 135-139. (Pubitemid 28498384)
27. Benowitz NL, Bernert JT, Caraballo RS, et al. Optimal serum cotinine levels for distinguishing cigarette smokers and nonsmokers within different racial/ethnic groups in the United States between 1999 and 2004. Am J Epidemiol. 2009;169:236-248.
28. Benowitz NL. The use of biologic fluid samples in assessing tobacco smoke consumption. In: Grabowski J, Bell C, eds. Measurement in the Analysis and Treatment of Smoking Behavior. Rockville, MD: National Institute on Drug Abuse; 1983:6-26. (Pubitemid 15020396)
29. Benowitz NL, Schultz KE, Haller CA, et al. Prevalence of smoking assessed biochemically in an urban public hospital: a rationale for routine cotinine screening. Am J Epidemiol. 2009;170:885-891.
30. Marrone GF, Shakleya DM, Scheidweiler KB, et al. Relative performance of common biochemical indicators in detecting cigarette smoking. Addiction. 2011;106:1325-1334.
31. Cooke F, Bullen C, Whittaker R, et al. Diagnostic accuracy of NicAlert cotinine test strips in saliva for verifying smoking status. Nicotine Tob Res. 2008;10:607-612. (Pubitemid 351566546)
32. Lea RA, Dickson S, Benowitz NL.Within-subject variation of the salivary 3HC/COT ratio in regular daily smokers: prospects for estimating CYP2A6 enzyme activity in large-scale surveys of nicotine metabolic rate. J Anal Toxicol. 2006;30:386-389. (Pubitemid 44274073)